Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial

Neurological Research
Yi DongQiang Dong

Abstract

Objectives: Intravenous thrombolysis and thrombectomy are recommended for patients whose stroke onsets are within first 6 h, and very few options are available for patients whose stroke onset is more than 6 h, which includes most ischemic stroke patients. Human urinary kallidinogenase (HUK) showed potential clinical benefits in acute ischemic stroke patients. This study aims to investigate the safety and clinical benefits of HUK in ischemic stroke patients.Patients and methods: Patients were recruited for a multicenter double-blind, placebo-controlled phase II b and phase III trial. Neurophysiological outcomes were assessed by the European Stroke Scale (ESS) and the functional outcomes were assessed by the activity of daily living scale (ADL). Safety was monitored by recording adverse events.Results: The improvements in ESS scores and ADL scores in the HUK group were significantly greater than that in patients receiving placebo. Furthermore, HUK treatment was also associated with a lower rate of disable, according to ADL. HUK-related adverse events occurred at a low rate, in 1.73% of HUK-treated patients.Conclusion: HUK is safe and provides potential clinical benefits as a treatment for acute ischemic stroke. Further large post...Continue Reading

References

Nov 1, 1994·Stroke; a Journal of Cerebral Circulation·L HantsonL Herroelen
Feb 7, 2003·Current Pharmaceutical Design·Costanza Emanuelia, Paolo Madeddu
Dec 28, 2005·Mechanisms of Ageing and Development·Viviana PérezFelipe Sierra
May 15, 2008·Cerebrovascular Diseases·UNKNOWN European Stroke Organisation (ESO) Executive Committee, UNKNOWN ESO Writing Committee
Feb 25, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Zhi-bin ChenYun Xu
Feb 27, 2010·Stroke; a Journal of Cerebral Circulation·E Clarke HaleyUNKNOWN Tenecteplase in Stroke Investigators
Feb 6, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Sameer BansalPooja Khatri
Nov 12, 2013·International Journal of Stroke : Official Journal of the International Stroke Society·F C GoldieUNKNOWN VISTA Collaboration
May 16, 2014·International Journal of Stroke : Official Journal of the International Stroke Society·H Bart van der WorpUNKNOWN EuroHYP-1 investigators
Jul 4, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Jingwei LiYun Xu
Jan 23, 2016·CNS Drugs·Nicola LogalloLars Thomassen
Jan 30, 2016·British Journal of Anaesthesia·Z SunUNKNOWN Study Group for Perioperative Stroke In China (POSIC)
Apr 21, 2016·Neurosciences : the Official Journal of the Pan Arab Union of Neurological Sciences·Jing MiaoJia C Feng

❮ Previous
Next ❯

Citations

Sep 22, 2021·Immunological Investigations·Hongjun LiMei Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.